Journal
CANCER CELL
Volume 22, Issue 4, Pages 494-505Publisher
CELL PRESS
DOI: 10.1016/j.ccr.2012.08.017
Keywords
-
Categories
Funding
- NIH/NIGMS [GM55479-16]
- American Asthma Foundation [09-0234]
- NIH [2 U19 AI070489-09]
Ask authors/readers for more resources
Thymic Stromal Lymphopoietin (TSLP), a cytokine implicated in induction of T helper 2 (Th2)-mediated allergic inflammation, has recently been shown to stimulate solid tumor growth and metastasis. Conversely, studying mice with clonal loss of Notch signaling in their skin revealed that high levels of TSLP released by barrier-defective skin caused a severe inflammation, resulting in gradual elimination of Notch-deficient epidermal clones and resistance to skin tumorigenesis. We found CD4(+) T cells to be both required and sufficient to mediate these effects of TSLP. Importantly, TSLP overexpression in wild-type skin also caused resistance to tumorigenesis, confirming that TSLP functions as a tumor suppressor in the skin.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available